Keywords: CVDs; cardiovascular diseases; ECs; endothelial cells; VSMCs; vascular smooth muscle cells; HPTMs; histones post-translational modifications; nt; nucleotides; 5-mC; 5-methylcytosine; 5-hmC; 5-hydroxymethylcytosine; CpG; sequence of cytosine followed by a
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ac; acetylation; BET; bromodomain and extra terminal family proteins; BMP7; bone morphogenic protein 7; BRD4; bromodomain-containing protein 4; bp; base pairs; CKD; chronic kidney disease; CTGF; connective tissue growth factor; DDR; DNA damage response; D
Keywords: Preeclampsia; Cardiovascular disease; Atherosclerosis; Endothelial dysfunction; Inflammation; endMT;
Keywords: EndMT; Fibrosis; TGF-β1; Microtubules; N-cadherin; Cell migration;
Keywords: α-SMA; α-Smooth muscle actin; DMEM; Dulbecco's Modified Eagle's Medium; EC; endothelial cell; EndMT; endothelial-mesenchymal transition; eNOS; endothelial nitric oxide synthase; FBS; fetal bovine serum; FSP1; fibroblast-specific protein 1; GM-CSF; granu
Keywords: EndMT; endothelial to mesenchymal transition; VECs; valve endothelial cells; VICs; valve interstitial cells; qPCR; quantitative reverse transcriptase polymerase chain reaction; TGFβ; transforming growth factor β; α-SMA; α-smooth muscle actin; Chm1; ch
Keywords: CTGF; connective tissue growth factor; ECM; extracellular matrix; EMT; epithelial-mesenchymal-transition; EndMT; endothelial-mesenchymal-transition; FGF; fibroblast growth factor; IL; interleukin; MMP; matrix metalloproteinase; TGF; transforming growt
Keywords: ADMA; asymmetric dimethyl arginine; ANG; angiopoietin-2; CKD; chronic kidney disease; END; endostatin; EndMT; endothelial to mesenchymal transformation; ESRD; end stage renal disease; HCAECs; human coronary artery endothelial cells; NO; nitric oxide; TSP;
Functions and mechanisms of microRNA-31 in human cancers
Keywords: 3â²-UTRs3â²; -untranslated regions; ADC; Adenocarcinoma; BC; Breast cancer; BER; base excision repair; CDK4; cyclin-dependent kinase 4; CRC; Colorectal cancer; CRT; chemo-radiation therapy; C-TAD; COOH terminal transactivation domain; DHR1; dihydrorhoda
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
Keywords: AGEs; advanced glycation end-products; ARE; antioxidant-response element; AP; argpyrimidine (Náº-(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-l-ornithine); BBB; blood-brain barrier; Casp-3; Caspase-3; CCM; Cerebral Cavernous Malformation; CNS; central nervous
The role of miR-328 in high glucose-induced endothelial-to-mesenchymal transition in human umbilical vein endothelial cells
Keywords: High glucose; HUVECs; miR-328; TGF-β1; EndMT; MEK1/2-ERK1/2;
Accelerated Endothelial to Mesenchymal Transition Increased Fibrosis via Deleting Notch Signaling in Wound Vasculature
Keywords: α-SMA; alpha-smooth muscle actin; EndMT; endothelial to mesenchymal transition; FGF2; fibroblast growth factor 2; FSP-1; fibroblast-specific protein 1; TGF-β; transforming growth factor-β2; YFP; yellow fluorescent protein;
Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium
Keywords: BBS8; Bardet-Biedl syndrome 8; bFGF; basic fibroblast growth factor; BMP; bone morphogenetic protein; BMSCs; bone marrow-derived hematopoietic stem cells; ECM; extracellular matrix; EGF; epidermal growth factor; EMT; epithelial-to-mesenchymal transition;
MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway
Keywords: MicroRNA; Notch2; EndMT; Fibrosis; High glucose;
Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)
Keywords: COPD; EMT; EndMT; Lung cancer; Fibrosis;
Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases
Keywords: EndMT; Cardiovascular diseases; Fibrotic disorders; Atherosclerosis;
The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment
Keywords: MRTFs; ILK; EndMT; CAFs; MMP9; Tumor microenvironments;
Epicardium-derived fibroblasts in heart development and disease
Keywords: MI; myocardial infarction; HHD; hypertensive heart disease; HI; hypertensive injury; ECM; extracellular matrix; CF; cardiac fibroblast; EMT; epithelial-to-mesenchymal transition; EndMT; endothelial-to-mesenchymal transition; EPDCs; epicardium-derived cell
Integrins and integrin-related proteins in cardiac fibrosis
Keywords: α-SMA; α-smooth muscle actin; Ang II; angiotensin II; CFs; cardiac fibroblasts; CM; cardiac myocyte; ED-A FN; ED-A fibronectin; EC; endothelial cells; EndMT; endothelial-mesenchymal transition; EMT; epithelial-mesenchymal transition; ECM; extracellu
Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis
Keywords: apoptosis; gene therapy; heart failure; NFκB; AAV; adeno-associated virus; CF; cardiac fibrosis; EndMT; endothelial-mesenchymal transition; FACS; fluorescence-activated cell sorting; HCAEC; human coronary artery endothelial cell; HF; heart failure; LV; l
Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin
Keywords: CCM; cerebral cavernous malformation; fCCM; familial form of CCM; sCCM; sporadic form of CCM; NVU; neurovascular unit; ICH; intracerebral hemorrhage; ROS; reactive oxygen species; COX-2; cycloxygenase-2; AJ; adherens junction; EndMT; endothelial-to-mesenc
Non-coding RNAs as modulators of the cardiac fibroblast phenotype
Keywords: CFs; cardiac fibroblasts; ECM; extracellular matrix; Alpha-SMA; alpha smooth muscle actin; SMemb; non-muscle myosin heavy chain; TGF-beta; transforming growth factor-beta; IL1-beta; interleukin 1-beta; TNF-alpha; tumor necrosis factor-alpha; MI; myocardia
Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression
Keywords: Kallistatin; EndMT; miR-21; eNOS; TGF-β; Oxidative stress;
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
Keywords: CD26; CD29; EndMT; Flt1; Flk1; smad3;
Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK
Keywords: VEC; valve endothelial cells; EndMT; endothelial to mesenchymal transformation; TGFβ; transforming growth factor-β; CAEC; carotid artery endothelial cells; α-SMA; α-smooth muscle actin; AT1; angiotensin II type 1 receptor; AT2; angiotensin II type 2 r
IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner
Keywords: αSMA; α-smooth muscle actin; DMSO; dimethylsulfoxide; DN-IκBα; dominant negative-NFκB inhibitor alpha; ECM; endothelial cell medium (or extracellular matrix); EndMT; endothelial to mesenchymal transition; eNOS; endothelial nitric oxide synthase; GAPD
Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
Keywords: Notch signaling; EMT; EndMT; Cancer stem cells; Notch inhibitorsADAM10/17, A Disintegrin And Metalloprotease 10/17; CSCs, cancer stem cells; CSL, CBF-1, Suppressor of Hairless/LAG1; EGFR, epidermal growth factor receptor; EMT, epithelial mesenchymal trans